Daniel Teper
pharma
immune pharmaceuticals
France
Biography
Dr. Daniel Teper is the founder Immune Pharmaceuticals and Chief Executive Officer of the company’s immuno-oncology subsidiary, Cytovia. He served as Chief Executive Officer of Immune Pharmaceuticals from its founding until April 2017. . He was the Managing Director for North America at Bionest Partners, a global Strategy Consulting firm advising pharmaceutical and public biotechnology companies and previously a New York based Partner at ISO Healthcare Consulting (now part of Deloitte Monitor).
Research Interest
Dr. Daniel Teper is the founder Immune Pharmaceuticals and Chief Executive Officer of the company’s immuno-oncology subsidiary, Cytovia. He served as Chief Executive Officer of Immune Pharmaceuticals from its founding until April 2017. . He was the Managing Director for North America at Bionest Partners, a global Strategy Consulting firm advising pharmaceutical and public biotechnology companies and previously a New York based Partner at ISO Healthcare Consulting (now part of Deloitte Monitor).
